HomeAI · summaries
Storia in 3 fonti
Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
The FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathy
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
What's Going on with Vera Therapeutics Stock on Monday? - Vera Therapeutics (NASDAQ:VERA)
Vera Therapeutics awaits the FDA's July 7 decision on atacicept for IgA nephropathy as investors weigh trial data and competition from Novartis.
- ·
fiercepharma.com
FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no FDA-approved treatment options. | When Vera…
